125 related articles for article (PubMed ID: 31552709)
1. FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection.
Karanth S; Chaurasia B; Bowman FM; Tippetts TS; Holland WL; Summers SA; Schlegel A
Physiol Rep; 2019 Sep; 7(18):e14238. PubMed ID: 31552709
[TBL] [Abstract][Full Text] [Related]
2. A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose.
Karanth S; Adams JD; Serrano MLA; Quittner-Strom EB; Simcox J; Villanueva CJ; Ozcan L; Holland WL; Yost HJ; Vella A; Schlegel A
Cell Rep; 2018 Jul; 24(2):312-319. PubMed ID: 29996093
[TBL] [Abstract][Full Text] [Related]
3. FOXN3 Regulates Hepatic Glucose Utilization.
Karanth S; Zinkhan EK; Hill JT; Yost HJ; Schlegel A
Cell Rep; 2016 Jun; 15(12):2745-55. PubMed ID: 27292639
[TBL] [Abstract][Full Text] [Related]
4. FOXN3 hyperglycemic risk allele and insulin sensitivity in humans.
Erickson ML; Karanth S; Ravussin E; Schlegel A
BMJ Open Diabetes Res Care; 2019; 7(1):e000688. PubMed ID: 31543974
[TBL] [Abstract][Full Text] [Related]
5. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
[TBL] [Abstract][Full Text] [Related]
6. Control of blood glucose in the absence of hepatic glucose production during prolonged fasting in mice: induction of renal and intestinal gluconeogenesis by glucagon.
Mutel E; Gautier-Stein A; Abdul-Wahed A; Amigó-Correig M; Zitoun C; Stefanutti A; Houberdon I; Tourette JA; Mithieux G; Rajas F
Diabetes; 2011 Dec; 60(12):3121-31. PubMed ID: 22013018
[TBL] [Abstract][Full Text] [Related]
7. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of oestrogen and progesterone effects on lipid and carbohydrate metabolism: alteration in the insulin: glucagon molar ratio and hepatic enzyme activity.
Mandour T; Kissebah AH; Wynn V
Eur J Clin Invest; 1977 Jun; 7(3):181-7. PubMed ID: 19260
[TBL] [Abstract][Full Text] [Related]
9. The hepatic FOXQ1 transcription factor regulates glucose metabolism in mice.
Cui Y; Qiao A; Jiao T; Zhang H; Xue Y; Zou Y; Cui A; Fang F; Chang Y
Diabetologia; 2016 Oct; 59(10):2229-39. PubMed ID: 27421728
[TBL] [Abstract][Full Text] [Related]
10. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice.
Yang W; Liao W; Li X; Ai W; Pan Q; Shen Z; Jiang W; Guo S
Diabetologia; 2023 Jul; 66(7):1322-1339. PubMed ID: 37202506
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
Goyal N; Tiwary S; Kesharwani D; Datta M
J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
[TBL] [Abstract][Full Text] [Related]
12. EP
Higuchi S; Fujikawa R; Nakatsuji M; Yasui M; Ikedo T; Nagata M; Mishima K; Irie K; Matsumoto M; Yokode M; Minami M
Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E410-E417. PubMed ID: 30562059
[TBL] [Abstract][Full Text] [Related]
13. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.
Zhang W; Patil S; Chauhan B; Guo S; Powell DR; Le J; Klotsas A; Matika R; Xiao X; Franks R; Heidenreich KA; Sajan MP; Farese RV; Stolz DB; Tso P; Koo SH; Montminy M; Unterman TG
J Biol Chem; 2006 Apr; 281(15):10105-17. PubMed ID: 16492665
[TBL] [Abstract][Full Text] [Related]
14. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice.
Vecchi C; Montosi G; Garuti C; Corradini E; Sabelli M; Canali S; Pietrangelo A
Gastroenterology; 2014 Apr; 146(4):1060-9. PubMed ID: 24361124
[TBL] [Abstract][Full Text] [Related]
15. Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses.
Chen Z; Sheng L; Shen H; Zhao Y; Wang S; Brink R; Rui L
Diabetes; 2012 Mar; 61(3):566-73. PubMed ID: 22315325
[TBL] [Abstract][Full Text] [Related]
16. FoxO6 integrates insulin signaling with gluconeogenesis in the liver.
Kim DH; Perdomo G; Zhang T; Slusher S; Lee S; Phillips BE; Fan Y; Giannoukakis N; Gramignoli R; Strom S; Ringquist S; Dong HH
Diabetes; 2011 Nov; 60(11):2763-74. PubMed ID: 21940782
[TBL] [Abstract][Full Text] [Related]
17. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange.
Liu Y; Dentin R; Chen D; Hedrick S; Ravnskjaer K; Schenk S; Milne J; Meyers DJ; Cole P; Yates J; Olefsky J; Guarente L; Montminy M
Nature; 2008 Nov; 456(7219):269-73. PubMed ID: 18849969
[TBL] [Abstract][Full Text] [Related]
18. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
[TBL] [Abstract][Full Text] [Related]
19. Male Men1 heterozygous mice exhibit fasting hyperglycemia in the early stage of MEN1.
Gao Z; Zhang L; Xie W; Wang S; Bao X; Guo Y; Zhang H; Hu Q; Chen Y; Wang Z; Xue M; Jin G
J Endocrinol; 2016 Sep; 230(3):347-55. PubMed ID: 27432891
[TBL] [Abstract][Full Text] [Related]
20. PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes.
Yano H; Sakai M; Matsukawa T; Yagi T; Naganuma T; Mitsushima M; Iida S; Inaba Y; Inoue H; Unoki-Kubota H; Kaburagi Y; Asahara SI; Kido Y; Minami S; Kasuga M; Matsumoto M
Sci Rep; 2018 Sep; 8(1):14290. PubMed ID: 30250231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
